Table 1.
Study & year | Cancer | Cancer type(system) | Sample size | Country | Stage | Age | Follow-up (months) | Comparisons | Cut off value | Method |
---|---|---|---|---|---|---|---|---|---|---|
Nagao 2012 [17] | PDAC | Other | 79 | Japan | I-IV | 65 | 40 | NG | Mean | qRT-PCR |
Shibuya 2010 [31] | CRC | Digestive | 156 | Japan | *A-D | 65 | 60 | Normal tissues& | Mean | qRT-PCR |
Gao 2010 [11] | NSCLC | Respiratory | 47 | China | I-III | 64 | 60 | Normal tissues | Median | qRT-PCR |
Childs 2009 [32] | HNSCC | Other | 104 | USA | I-IV | 60 | 60 | Normal tissues | Mean | qRT-PCR |
Yan 2008 [33] | BC | Breast | 113 | China | I-III | 48 | 66.2 | Normal tissues | Mean | qRT-PCR |
Lee 2011 [35] | BC | Breast | 109 | Korea | I-III | 48 | 100 | NG | Mean | qRT-PCR |
Jiang 2011 [36] | Melanoma | Other | 106 | China | I-IV | 60 | 60 | NG | Median | qRT-PCR |
Zhi 2010 [37] | Astrocytoma | Other | 124 | China | I-IV | 47.8 | 35.2 | NG | Median | qRT-PCR |
Jamieson 2012 [38] | PDAC | Other | 58 | UK | II,III | 65 | 23.9 | Normal tissues | Median | qRT-PCR |
Schetter 2008 [39] | CRC | Digestive | 84 | USA | I-IV | 64.6 | 68.0 | Normal tissues | Highest tertile | qRT-PCR |
Schetter 2008 [39] | CRC | Digestive | 113 | HK | I-IV | 55.8 | 84.6 | Normal tissues | Dichotomize | Microarray |
Faltejskova 2012 [41] | CRC | Digestive | 44 | Czech | I-IV | 67 | 84 | Normal tissues | Median | qRT-PCR |
Chen 2013 [42] | CRC | Digestive | 195 | Taiwan | I-IV | 66 | 60 | Normal tissues | Mean | qRT-PCR |
Toiyama 2013 [43] | CRC | Digestive | 186 | Japan | I-IV | 67 | 60 | Normal tissues | 0.0031 | qRT-PCR |
Markou 2008 [13] | NSCLC | Respiratory | 48 | USA | I-IV | 60 | 50 | Healthy controls | 2-fold | qRT-PCR |
Liu2012 [44] | NSCLC | Respiratory | 70 | China | I-IV | 60 | 30 | Healthy controls | 2-fold | qRT-PCR |
Saito2011 [45] | NSCLC | Respiratory | 89 | USA | I-III | 63.6 | 80 | Normal tissues | Median | qRT-PCR |
Saito2011 [45] | NSCLC | Respiratory | 37 | Norway | I-III | 64.4 | 80 | Normal tissues | Median | qRT-PCR |
Saito2011 [45] | NSCLC | Respiratory | 191 | Japan | I-III | 59.6 | 80 | Normal tissues | Median | qRT-PCR |
Markou 2013 [46] | NSCLC | Respiratory | 48 | Greece | I-IV | 60 | 40 | Normal tissues | 6.3-fold | qRT-PCR |
Wu2013 [56] | Glioma | Other | 152 | China | I-IV | 45.1 | 60 | Normal tissues | Mean | qRT-PCR |
Papaconstantinou2012 [57] | PC | Other | 88 | Greece | I-IV | 66.5 | 40 | Normal tissues | Mean | qRT-PCR |
Karakatsanis2011 [48] | HCC | Digestive | 60 | Greece | I-IV | 60 | 50 | Healthy controls | Mean | qRT-PCR |
Kadera2013 [49] | PDAC | Other | 153 | USA | I, II,IV | 65 | 42 | Healthy controls | Median | ISH |
Markou 2014 [58] | BC | Breast | 112 | Greece | 60 | 75 | Normal tissues | Median | qRT-PCR | |
Akagi2013 [50] | LC | Respiratory | 67 | USA | I | 64.9 | 60 | Normal tissues | Median | qRT-PCR |
Akagi2013 [50] | LC | Respiratory | 25 | Norway | I | 64.0 | 60 | Normal tissues | Median | qRT-PCR |
Bovell2013 [51] | CC | Digestive | 345 | USA | IV | 65 | 17 | Normal tissues | Mean | qRT-PCR |
Capodanno 2013 [52] | NSCLC | Respiratory | 80 | Italy | I-IV | 67 | 32 | Normal tissues | Median | qRT-PCR |
Faragalla2012 [53] | RCC | Digestive | 121 | Canada | I-III | 62.4 | 52.8 | Normal tissues | 40th percentile | qRT-PCR |
Mathe 2009 [55] | ESCC | Digestive | 69 | Two countries | I-IV | 62 | 62.5 | Normal tissues | Dichotomize | qRT-PCR |
Abbreviations: PDAC pancreatic ductal adenocarcinoma, CRC colorectal cancer, NSCLC non-small cell lung cancer, HNSCC head and neck squamous cell carcinoma, CC colon cancer, RC rectal cancer, HCC hepatocellular carcinoma, ESCC oesophageal squamous cell carcinoma, BC breast cancer, PC pancreatic cancer, RCC renal cell carcinoma, *Duke’s stage, ISH In Situ Hybridization, NG Not given, &Adjacent noncancerous tissues were procured from patients.